References - Theoretical Essay A

1. Bendelac A, Boitard C, Bedossa P, Bazin H, Bach JF, Carnaud C. Adoptive T cell transfer of autoimmune nonobese diabetic mouse diabetes does not require recruitment of host B lymphocytes. J Immunol 1988; 141:2625-2628.

2. Miller BJ, Appel MC, O'Neil JJ, Wicker LS. Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. J Immunol 1988; 140:52-58.

3. Wang Y, Pontesilli O, Gill RG, La Rosa FG, Lafferty KJ. The role of CD4+ and CD8+ T cells in the destruction of islet grafts by spontaneously diabetic mice. Proc Natl Acad Sci U.S.A. 1991; 88:527-531.

4. Christianson SW, Shultz LD, Leiter EH. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors. Diabetes 1993; 42:44-55.

5. Bradley BJ, Haskins K, La Rosa FG, Lafferty KJ. CD8 T cells are not required for islet destruction induced by a CD4+ islet-specific T-cell clone. Diabetes 1992; 41:1603-1608.

6. Wegmann DR, Shehadeh N, Lafferty KJ, Norbury-Glaser M, Gill RG, Daniel D. Establishment of islet-specific T-cell lines and clones from islet isografts placed in spontaneously diabetic NOD mice. J Autoimmun. 1993; 6:517-527.

7. Hutchings PR, Simpson E, O'Reilly LA, Lund T, Waldmann H, Cooke A. The involvement of Ly2+ T cells in beta cell destruction. J Autoimmun. 1990; 3 Suppl 1:101-9:101-109.

8. Gill RG, Lafferty KJ. A novel form of T-T collaboration requiring the active participation of the antigen presenting cell. Ann NY Acad Sci 1989; 532:421-425.

9. Kemeny DM, Noble A, Holmes BJ, Diaz-Sanchez D. Immune regulation: a new role for the CD8+ T cell. Immunol Today 1994; 15:107-110.

10. Wilberz S, Partke HJ, Dagnaes-Hansen F, Herberg L. Persistent MHV (mouse hepatitis virus) infection reduces the incidence of diabetes mellitus in non-obese diabetic mice. Diabetologia 1991; 34:2-5.

11. Jahnke U, Fischer EH, Alvord ECJ. Sequence homology between certain viral proteins and proteins related to encephalomyelitis and neuritis. Science 1985; 229:282-284.

12. Shehadeh NN, LaRosa F, Lafferty KJ. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J Autoimmun. 1993; 6:291-300.

13. Scott B, Lo D. Peripheral tolerance and CD4 cell. In: Bluthmann H, Ohashi P, editors. Analysis of the Immune System Utilising Transgenesis and Targeted Mutagenesis. Orlando: Academic Press, 1993:

14. Nomikos IN, Prowse SJ, Carotenuto P, Lafferty KJ. Combined treatment with nicotinamide and desferrioxamine prevents islet allograft destruction in NOD mice. Diabetes 1986; 35:1302-1304.

15. Rakieten N, Gordon BS, Beaty A, Cooney DA, Davis RD, Schein PS. Pancreatic islet cell tumors produced by the combined action of streptozotocin and nicotinamide. Proc Soc.Exp.Biol.Med 1971; 137:280-283.

16. Sadelain MW, Qin HY, Lauzon J, Singh B. Prevention of type I diabetes in NOD mice by adjuvant immunotherapy. Diabetes 1990; 39:583-589.

17. Shehadeh N, Calcinaro F, Bradley BJ, Bruchlim I, Vardi P, Lafferty KJ. Effect of adjuvant therapy on development of diabetes in mouse and man [see comments]. Lancet 1994; 343:706-707.